United States · Biotechnology startup
United States · Syros Pharmaceuticals
Syros Pharmaceuticals is a life sciences company that focuses on treating diseases by mapping gene regulatory circuits.
Funding reportedLast round: Post ipo equity
What company datasets say Syros Pharmaceuticals raised
Funding, as reported
Reported in all$620Min dollars
Rounds11
Last roundPost ipo equity
Last round dateDec 2023
Investors listed23
Founders and team
From the SEC filings it signed: 6 on the team.
- Conely C. CheeExecutive Officeri
- David C. RothExecutive Officeri
- Eric C. OlsonExecutive Officeri
- Jason C. HaasExecutive Officeri
- Kristin C. StephensExecutive Officeri
- Nancy SimonianExecutive Officer, Directori
On the board, as filediAndrew C. OhDeborah DunsireMark AllesMarsha A. FanucciPeter WirthRichard A. YoungSrinivas AkkarajuSue Gail EckhardtTimothy C. Tyson
On 2 portfolio pages
Investors who name them
Each firm lists Syros Pharmaceuticals on its own website. That is the firm's claim, a weaker thing than a round we watched, but a named source.
Biotechnology in United States
Startups like it
- SojournixWaltham · founded 2016Raised
- Receptor Life SciencesSeattle · founded 2017Raised
- Attune PharmaceuticalsNew York · founded 2018Raised
AbbVieNorth Chicago · founded 2012
GrailMenlo Park · founded 2015
EQRxCambridge · founded 2019- Cerevel TherapeuticsBoston · founded 2018
Royalty PharmaNew York · founded 1996
Is this your company?
Add your raise, your deck and your story, and put Syros Pharmaceuticals in front of investors. Or tell us what we have wrong.